Related Experiment Video
Updated: Mar 7, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells
Bin Liu1, Kaiqiao Jia1, Yu Yang2
1Laboratory of Hepatobiliary Surgery, Zhanjiang Key Laboratory of Hepatobiliary Diseases, Guangdong Medical University, Zhanjiang 524001. China.
Abstract:
It was explored that CYP1 family of cytochromes P450 were over-expressed in several types of cancer. Our study aimed to characterize anti-proliferative activity and metabolism of the natural flavonoid diosmetin in the human hepatoma cell HepG2, expressing CYP1 family. Diosinduced cell apoptosis could be reversed due to p53 blockade and the cellular P53 and CYP1A1/CYP1A2 proteins levels were examined. P53 and CYP1A1/CYP1A2 proteins were upregulated by Dios; when PFT-α was added into cells, the P53 levels were down-regulated accompanied with up-regulated CYP1A1/CYP1A2. Meanwhile, when cells were co-treated with Dios and PFT-α, P53 was down-regulated and CYP1A1/CYP1A2 up-regulated controlled with that of Dios treated cells. The data reveal the new evidence that cytochrome P450 CYP1A regulation by P53 enzyme plays an important role in Diosmetin anti-cancer activity of HepG2 cells.
Insights
Diosmetin, a natural flavonoid, shows anti-cancer effects by inducing apoptosis in HepG2 cells. This activity involves the p53 enzyme regulating Cytochrome P450 CYP1A, crucial for diosmetin
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Cytochrome P450 (CYP) enzymes, particularly the CYP1 family, are often overexpressed in various cancers.
- Natural compounds like flavonoids are being investigated for their potential anti-cancer properties.
Purpose of the Study:
- To investigate the anti-proliferative effects and metabolism of the flavonoid diosmetin in human hepatoma HepG2 cells.
- To explore the role of p53 and Cytochrome P450 CYP1A1/CYP1A2 in diosmetin's anti-cancer activity.
Main Methods:
- Utilized human hepatoma HepG2 cells expressing CYP1 family enzymes.
- Administered diosmetin and PFT-α (p53 blockade) to cells, examining protein levels of p53 and CYP1A1/CYP1A2.
- Assessed diosmetin-induced apoptosis and its modulation by p53 blockade.
Main Results:
- Diosmetin treatment upregulated both p53 and CYP1A1/CYP1A2 protein levels in HepG2 cells.
- PFT-α treatment downregulated p53 while upregulating CYP1A1/CYP1A2.
- Co-treatment with diosmetin and PFT-α resulted in downregulated p53 and upregulated CYP1A1/CYP1A2, similar to diosmetin alone.
Conclusions:
- Diosmetin induces apoptosis in HepG2 cells, an effect that can be reversed by blocking p53.
- The p53 enzyme plays a significant role in regulating Cytochrome P450 CYP1A, mediating diosmetin's anti-cancer effects in HepG2 cells.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
Abnormal Proliferation
Mitogens and the Cell Cycle
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway